My understanding of the announcement is that SAD study will NOW commence, in other words, we had already conceived a definitive plan, (with costings), and were simply awaiting the formal FDA clearance, now provided, thus we were indeed ready to go and now we are proceeding right away! Which is great news IMO.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)